Evidence map›Paper›PMID 31775355›Full record

ReviewMolecules (Basel, Switzerland)2019

What Is in Store for EPS Microalgae in the Next Decade?

Guillaume Pierre, Cédric Delattre, Pascal Dubessay, Sébastien Jubeau, Carole Vialleix, Jean-Paul Cadoret, Ian Probert, Philippe Michaud

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Efficiency ofMaterials (Basel, Switzerland) · 2025
    Article
  5. Rhamnose biosynthesis is not impaired by the deletion of putativeApplied and environmental microbiology · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Effects of nitrate limitation on the metabolome ofCurrent research in microbial sciences · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guillaume PierreUniversité Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.ORCID 0000-0001-9919-7058
Cédric DelattreUniversité Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.ORCID 0000-0003-3605-1929
Pascal DubessayUniversité Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.
Sébastien JubeauXanthella, Malin House, European Marine Science Park, Dunstaffnage, Argyll, Oban PA37 1SZ, Scotland, UK.
Carole VialleixGreenSea Biotechnologies, Promenade du sergent Navarro, 34140 Meze, France.
Jean-Paul CadoretGreenSea Biotechnologies, Promenade du sergent Navarro, 34140 Meze, France.
Ian ProbertStation Biologique de Roscoff, Place Georges Teissier, 29680 Roscoff, France.
Philippe MichaudUniversité Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000 Clermont-Ferrand, France.ORCID 0000-0002-6677-4549

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microalgae and their metabolites have been an El Dorado since the turn of the 21st century. Many scientific works and industrial exploitations have thus been set up. These developments have often highlighted the need to intensify the processes for biomass production in photo-autotrophy and exploit all the microalgae value including ExoPolySaccharides (EPS). Indeed, the bottlenecks limiting the development of low value products from microalgae are not only linked to biology but also to biological engineering problems including harvesting, recycling of culture media, photoproduction, and biorefinery. Even respecting the so-called "Biorefinery Concept", few applications had a chance to emerge and survive on the market. Thus, exploiting EPS from microalgae for industrial applications in some low-value markets such as food is probably not a mature proposition considering the competitiveness of polysaccharides from terrestrial plants, macroalgae, and bacteria. However, it does not imply drawing a line on their uses but rather "thinking them" differently. This review provides insights into microalgae, EPS, and their exploitation. Perspectives on issues affecting the future of EPS microalgae are also addressed with a critical point of view.

Indexed as

BioengineeringBiofuelsBiomassCulture MediaHumansMicroalgaePolysaccharidesSeaweedBiofuelsCulture MediaPolysaccharidesapplicationEPSexopolysaccharidesmarketmicroalgae

Identifiers

PMID31775355
PMCPMC6930497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.